ARTN and Alzheimer disease: These analysesmay bring the potential clinical use of Artemin and/or Artemin-derived peptides in patients with AD a stepcloser, provided that Artemin and/or its derivatives areable to inhibit TAU aggregation in cell-based assays aswell as in animal models of TAU aggregation.